[1]刘宇娜,苏衍进,司海龙,等.国医大师张学文瘀血理论治疗顽固性肾性水肿经验[J].陕西中医,2021,(4):506-509.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.027]
　LIU Yu'na,SU Yanjin,SI Hailong,et al.Analysis of the experience of treating refractory renal edema based on the blood stasis theory of ZHANG Xuewen[J].,2021,(4):506-509.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.027]
点击复制

国医大师张学文瘀血理论治疗顽固性肾性水肿经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年4期
页码:
506-509
栏目:
名中医经验
出版日期:
2021-04-05

文章信息/Info

Title:
Analysis of the experience of treating refractory renal edema based on the blood stasis theory of ZHANG Xuewen
作者:
刘宇娜1 ;  苏衍进2 ; 司海龙2; 王郁金1
(1.陕西中医药大学,陕西 咸阳 712046; 2.陕西中医药大学附属医院,陕西 咸阳 712021)
Author(s):
LIU Yu'na; SU Yanjin; SI Hailong; WANG Yujin
(Shaanxi University of Chinese Medicine,Xianyang 712046,China)
关键词:
顽固性肾性水肿;  瘀血理论;  张学文;  名医经验;  肾脏病
Keywords:
Intractable edema;  Blood stasis theory;  ZHANG Xuewen;  Famous medical experience;  Kidney disease
分类号:
R 265.51
DOI:
DOI:10.3969/j.issn.1000-7369.2020.04.027
文献标志码:
A
摘要:
本文旨在介绍从瘀血方面对顽固性肾性水肿病因病机认识及临床治疗用药经验。临床上诸多疾病均可有血瘀证,如胸痹、水肿、腰痛等,这主要与多种因素均可致瘀有关,各种致病因素发展到一定阶段均导致瘀血出现,因此临床上对血瘀证论治及其重要。国医大师张学文教授认为,水肿除需考虑一般病因引起,在疾病发展过程中,也不能忽略瘀血的存在,瘀血既为病理产物,又为其致病因素,临床上以健脾补肾、活血化瘀、行气利水为治疗原则。本文将介绍顽固性肾性水肿定义、瘀血理论成因、兼瘀血的不同证型及用药、典型病例,探讨国医大师张学文教授从瘀血理论辨证论治顽固性肾性水肿的临床用药,以期为临床诊疗提供更好的中医指导。
Abstract:
To introduce the etiology and pathogenesis of refractoryrenal edema from the aspect of blood stasis and the experience of clinical treatment.Many diseases can have blood stasis syndrome,such as chest obstruction,edema,low back pain and so on,which is mainly related to many factors can cause blood stasis,all kinds of pathogenic factors develop to a certain stage to lead to blood stasis,so clinical treatment of blood stasis syndrome and its importance.Professor ZHANG Xuewen believes that edema should not only be caused by general etiology,but also the existence of blood stasis can not be ignored in the course of disease development.Blood stasis is both a pathological product and a pathogenic factor.This article will introduce the definition of refractory renal edema,the causes of blood stasis theory,the different syndromes and medication of blood stasis,typical cases,to explore the famous doctor Professor ZHANG Xuewen from the theory of blood stasis syndrome differentiation treatment of refractory renal edema clinical medication,in order to provide better TCM guidance for clinical diagnosis and treatment.

参考文献/References:

[1] 杨 雄,高 伟,邱万胜,等.白蛋白球蛋白比值对慢性肾脏病患者预后判断的价值研究[J].陕西医学杂志,2020,49(6):728-731.
[2] Khan YH,Mallhi TH,Sarriff A,et al.Prevalence of chronic kidney disease in asia:A systematic review of population-based studies[J].J Coll Physicians Surg Pak,2018,28(12):960-966.
[3] 郑 栓.益气活血化湿方配合西医治疗慢性肾小球肾炎临床研究[J].亚太传统医药,2018,14(1):171-172.
[4] 程红卫,成晓萍.阎晓萍从脾论治糖尿病肾病经验总结[J].陕西中医,2019,40(6):790-792.
[5] 王 曾,陈洪宇,徐王达.陈洪宇从活血化瘀法论治肾病综合征经验[J].中华中医药杂志,2020,35(7):3466-3469.
[6] 何 松,苏 悦,常永龙,等.王清任《医林改错》活血化瘀思想探骊[J].福建中医药,2019,50(4):46-47.
[7] 潘龙康,杨改琴,毛 刚.《伤寒杂病论》之“瘀血”探析[J].江苏中医药,2020,52(5):9-12.
[8] 邓玉秀,刘德亮,张 卓,等.国医大师张学文血瘀证论治经验[J].中医药导报,2019,25(17):7-9.
[9] 曹兰秀,严亚锋.张学文教授采用活血化瘀法治疗心绞痛经验总结[J].陕西中医,2017,38(4):507-508.
[10] 周海哲.从《金匮要略》“血不利则为水”解析张学文教授论治颅脑水瘀证[J].新中医,2015,47(4):323-324.
[11] 朱玉辉,翟丽杰,张双福,等.灯盏细辛注射液联合尤瑞克林治疗气虚血瘀型早期急性缺血性脑卒中临床研究[J].陕西中医,2020,41(5):609-611.
[12] 林 浩,黄文辉,黄龙记,等.温阳利水法治疗难治性水肿体会[J].新中医,2019,51(4):284-286.
[13] 甘洪桥,吴 巍.吴康衡教授从痰瘀论治肾性水肿经验[J].四川中医,2016,34(6):1-3.
[14] 潘 莉,魏华娟,董绍英,等.赵玉庸教授辨治肾性水肿经验[J].中华中医药杂志,2015,30(1):137-139.
[15] 陈茂鑫,侯 敏.黄芪与红芪化学成分及药理作用研究进展与比较[J].中医药导报,2019,25(8):126-128.
[16] 潘琳琳,孙君艺,王 淞,等.国医大师张志远运用茯苓经验[J].中华中医药杂志,2020,35(2):699-702.
[17] 卜 兰,刘 菲,熊 亮,等.益母草属萜类化学成分及其药理作用研究进展[J].世界中医药,2020,15(9):1237-1246.
[18] 邓爱平,李 颖,吴志涛,等.苍术化学成分和药理的研究进展[J].中国中药杂志,2016,41(21):3904-3913.
[19] 张紫薇,梁尚华.“泽兰”药用史略考[J].中国中医基础医学杂志,2018,24(1):113-115.
[20] 康 磊,远 方.远方从瘀论治肾性水肿经验[J].湖北中医杂志,2016,38(8):30-31.

相似文献/References:

[1]宋渊杰,王 辉,石耀武,等.基于“从瘀论治”理论探讨活血化瘀药治疗脑卒中阿司匹林抵抗[J].陕西中医,2023,(10):1435.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.023]
　SONG Yuanjie,WANG Hui,SHI Yaowu,et al.Exploring the treatment of aspirin resistance in stroke by promoting blood circulation and resolving stasis drugs based on the theory of “treating from stasis”[J].,2023,(4):1435.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.023]

备注/Memo

备注/Memo:
基金项目:国家自然科学青年科学基金资助项目(81704066); 陕西省科学技术厅项目(2020SF-336); 陕西省中医药管理局项目(LCMS038)
更新日期/Last Update: 2021-04-09